Sign in
4

Changes in Ownership

CURIS INC Filed Acc 0001181431-08-005755

Options or other derivatives

  • VP, Research & Preclinical Dev acquired 180,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Qian Changgeng VP, Research & Preclinical Dev 2008-01-25 Grant or award · Qualified stock option (right to buy) +55,075 55,075 D: show line 1 in the form
Qian Changgeng VP, Research & Preclinical Dev 2008-01-25 Grant or award · Non-qualified stock option (right to buy) +124,925 124,925 D: show line 2 in the form
Loading xslF345X02/rrd192116.xml…